Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Majycc Innovation Santé is a venture capital fund established in 2022 through the merger of Majycc eSanté Invest and UI Investissement. Based in Paris, France, the fund focuses on supporting high-potential startups in the health sector, specifically in eHealth, MedTech, and BioTech. The organization aims to contribute to the creation of value for future health by backing ambitious projects that can drive innovation in healthcare.
The fund operates under the legal form of FPCI (Fonds Professionnel de Capital Investissement), which is a French professional investment fund. It is managed by UI Investissement, which has a total AUM exceeding €700 million across all its investment vehicles. Majycc Innovation Santé has a strong industrial backing, including partnerships with the SRS health group, Almaviva, and Monceau holding, which enhances its credibility and operational support in the healthcare sector.
Since its inception, Majycc has made significant strides in the venture capital landscape, focusing on late-stage investments in the health sector. The fund's strategic location in Paris allows it to maintain close ties with local economies and emerging companies, further solidifying its role in the European health innovation space.
Majycc Innovation Santé specializes in late-stage venture capital, particularly focusing on Series A and B funding rounds. The fund primarily invests in innovative health sectors across France and Europe, with a specific emphasis on eHealth, MedTech, and BioTech. This targeted approach allows Majycc to leverage its deep connections within the healthcare ecosystem, providing portfolio companies with essential support and resources.
The investment strategy of Majycc Innovation Santé is designed to identify and back high-potential startups that can create significant value in the health sector. The fund looks for companies that demonstrate strong growth potential and innovative solutions to existing healthcare challenges. In addition to financial investment, Majycc offers regulatory pathway guidance, market insights, and business development support to its portfolio companies, enhancing their chances of success in a competitive landscape.
Majycc Innovation Santé has made 4 investments to date, focusing on companies that align with its health sector strategy. Notably, the fund participated in a €32 million Series A round for Coave Therapeutics, which is recognized for its innovative approaches in the biotech space. The latest investment was made in dreem health in September 2025, showcasing the fund's ongoing commitment to supporting emerging health technologies.
While specific details about all portfolio companies are not disclosed, the fund's selective investment strategy indicates a focus on high-quality startups that can leverage the expertise and resources provided by Majycc. This approach not only enhances the potential for successful outcomes but also contributes to the overall advancement of health innovation in Europe.
Pauline de Breteuil - Directrice associée. Pauline has a background in developing health innovation funds and has joined UI Investissement to lead initiatives in this area.
Tanguy Besson - Chargé d'affaires senior. Tanguy brings expertise in managing investments and supporting portfolio companies within the health sector.
Startups interested in pitching to Majycc Innovation Santé should visit their website at majycc.com for detailed information on the application process. The fund prefers pitches that include a clear overview of the business model, market potential, and alignment with their investment focus in the health sector.
Founders should be prepared to provide insights into their team's background, product development status, and any existing partnerships or traction in the market. Response times may vary, so it is advisable to follow up after submitting a pitch to ensure it has been received and is under consideration.
In September 2025, Majycc Innovation Santé made a notable investment in dreem health, further expanding its portfolio in the health sector. This investment highlights the fund's ongoing commitment to supporting innovative health startups.
Previously, Majycc participated in a €32 million Series A round for Coave Therapeutics, showcasing its active role in funding high-potential biotech companies.
What are Majycc Innovation Santé's investment criteria?
Majycc Innovation Santé focuses on late-stage investments in the health sector, specifically targeting Series A and B funding rounds. The fund seeks high-potential startups in eHealth, MedTech, and BioTech that demonstrate strong growth potential and innovative solutions.
How can startups apply or pitch to Majycc Innovation Santé?
Startups interested in pitching to Majycc Innovation Santé can visit their website at majycc.com for more information on the application process. The fund encourages startups to present their business models, market potential, and how they align with Majycc's investment focus.
What makes Majycc Innovation Santé different from other venture capital firms?
Majycc Innovation Santé differentiates itself through its strong industrial backing from healthcare players like the SRS health group and Almaviva. This provides portfolio companies with valuable insights, regulatory guidance, and market access that are crucial for success in the health sector.
What is the geographic scope of Majycc Innovation Santé's investments?
The fund primarily invests in startups located in France and across Europe, focusing on innovative health sectors. This geographic focus allows Majycc to tap into a diverse range of health innovation opportunities.
What kind of post-investment involvement does Majycc Innovation Santé have with its portfolio companies?
Majycc Innovation Santé provides significant value-add to its portfolio companies through regulatory pathway guidance, market insights, and business development support. The fund's deep connections within the healthcare ecosystem facilitate ongoing collaboration and support for its investments.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.